Oleg Khaykin

CEO Oleg Khaykin sells ~260k shares worth $13.4M in two consecutive days, continuing pattern of poor-timing exits.

Oleg Khaykin, VIAVI's President and CEO, sold approximately 260,000 shares across two trading days for a combined $13.4 million. This marks the continuation of a stark pattern: all five of his prior sales at this company have seen the stock rise afterward, meaning he has exited at positions that proved to be local lows rather than peaks. While the stock has recovered sharply in recent months and is trading somewhat below its highs, the CEO's track record suggests his timing on exits remains consistently poor—he is systematically selling before rallies, not into them. The company remains profitable with growing annual revenue, though the most recent quarter showed a net loss, and the elevated valuation multiple reflects the market's current pricing of the business. This sale is notable not for what it says about Khaykin's confidence in VIAVI, but for what it reveals about his continued difficulty timing exits: a CEO who has sold frequently but never at inflection points where it mattered.

VIAV CEO Oleg Khaykin sells 34,024 shares, his third divestiture in two trading days amid sharp stock rally.

Oleg Khaykin, President and CEO of VIAVI Solutions, sold over 34,000 shares on May 6th, continuing a pattern of aggressive selling that has now included three separate transactions within two trading days. This comes as the stock has surged significantly from depressed lows, though it remains modestly below its recent highs. Notably, Khaykin's five prior sales in this stock all saw shares appreciate afterward—a track record indicating consistently poor timing on his exits, suggesting he has repeatedly sold too early. While the company remains profitable with growing annual revenue, the latest quarterly earnings turned negative, and the valuation now appears stretched, raising questions about whether the CEO's repeated exits reflect caution about near-term momentum or other concerns. The rapid succession of three sales within two days is unusual and worth monitoring for any signals of internal sentiment shifts, though the prior poor timing on exits limits how much conviction this pattern alone should command.

CEO Oleg Khaykin sold ~125k shares for $6.8M; stock near 52-week highs after sharp rally, but all prior exits poorly timed.

Oleg Khaykin, the company's President and CEO, sold approximately 125,000 shares in two transactions on the same day for a combined $6.8 million, disposing of about 7% of his holdings while retaining over a million shares. The sales occurred as the stock trades near its 52-week high following a strong recent rally, which might suggest opportunistic selling into strength. However, Khaykin's track record with VIAVI shares tells a cautionary tale: all five of his previous sales at this stock were poorly timed, with the stock climbing measurably after each exit. This pattern suggests he has historically misjudged exit points at this company. The company remains profitable with growing annual revenue, though the most recent quarter showed a net loss, creating mixed fundamental signals. Given the CEO's consistent difficulty timing exits at his own company and the current elevated price position, investors should monitor whether this sale marks the beginning of a sustained weakness or another instance of the insider selling prematurely into a continuing advance.

VIAV CEO Khaykin sold 62.8K shares for $1.7M on Feb 10; -75.6% of holdings retained. Stock +49% in 30d, +58.9% in 90d from lows.

OLEG KHAYKIN (President & CEO) executed 2 separate sales totaling 62,767 shares for $1,726,292.50 on 2026-02-10, reducing his holdings from 83,005 shares to 20,238 shares—a net reduction of 75.6%. The sales occurred at a blended average price of $27.50, near the 52-week high of $27.62. VIAV's stock has appreciated sharply in recent weeks (+49.0% over 30 days, +58.9% over 90 days), and the company reports a P/E ratio of 168.12 with negative net income of $-48,100,000.00 against quarterly revenue of $369,300,000.00. The combination of a substantial portfolio exit by the CEO at peak valuation, paired with the company's negative earnings profile and elevated forward multiples, merits investor scrutiny of near-term catalysts and fundamental sustainability.

VIAV CEO Oleg Khaykin sold 73,250 shares at $26.25 on Feb 9, 2026; stock near 52-week high of $27.62, up 55.3% in 30 days.

Oleg Khaykin, President & CEO of VIAVI Solutions, sold 73,250 shares (73.2K shares) at $26.25, reducing his holdings by 4.3% to 1,635,621 shares (1.64M shares). The sale occurred as the stock trades at $27.62, just 0.0% from its 52-week high following a sharp 55.3% 30-day rally. His prior trades at VIAV show only one measurable outcome (a December 2025 sale with +3.7% 30-day return), with four more recent sales in early February lacking outcome data yet. The company's fundamentals present a mixed picture: revenue of $369,300,000 and 8.4% annual growth are offset by a $-48,100,000 net loss and a stretched P/E of 172.62. The sale coincides with peak valuation momentum rather than distress signaling, though the absence of well-timed prior sales at this ticker leaves no historical pattern to establish whether the CEO's timing has been predictive.

VIAVI CEO Khaykin sells 70,566 shares in 2 transactions for $1,853,851.85 amid stock at 52-week high

Oleg Khaykin, President & CEO of VIAVI Solutions, executed 2 separate sales totaling 70,566 shares for $1,853,851.85 at prices of $26.30 and $26.25 on 2026-02-06, reducing his holdings by 4.0% to 1,708,871 shares. The sales occurred with the stock trading at $26.38, its 52-week high, following a 42.3% surge over the prior 30 days and 48.1% over 90 days. Khaykin's prior selling activity at VIAV shows a pattern of sales in early December and early February with modest positive 30-day returns, though no measurable 90-day outcomes are yet available for most recent trades. The sale's timing relative to the stock's recent momentum and valuation (P/E of 164.88 on a loss-making quarter of -$48.1M net income) warrants attention regarding near-term positioning, though the company's annual revenue growth of 8.4% provides underlying operational context.

VIAV CEO Khaykin sells 74,315 shares at $26.48; stock down -2.2% from 52-week high despite 36.3% 30-day gain.

CEO Oleg Khaykin sold 74,315 shares on 2026-02-04 at $26.48, reducing holdings from 1,923,752 shares to 1,849,437 shares (−3.9% of prior holdings), for total proceeds of $1,967,861.20. The sale occurred near the 52-week high: the stock was -2.2% from its $25.88 peak and has surged +36.3% over 30 days and +42.2% over 90 days. In context of his same-ticker history, Khaykin's five prior VIAV sales (2025-12-02 through 2026-02-05) showed modest positive 30-day outcomes ranging from +0.1% to +6.1%, though no 90-day outcomes are yet measurable; his cross-ticker track record across eight prior open-market sales averaged +2.2% 30-day returns. The company carries a negative net income of $-48,100,000 on quarterly revenue of $369,300,000, with elevated valuation metrics (P/E of 158.25, market cap $5,858,778,215.40) despite revenue growth of +8.4% year-over-year. This sale at a peak price following a sharp rally warrants tracking against future price action and earnings fundamentals.

VIAVI CEO Khaykin sold 70,000 shares at $24.50; still holds 1,779,437 shares post-transaction

CEO Oleg Khaykin sold 70,000 shares (70.0K shares) of VIAVI on 2026-02-05 at $24.50, representing a -3.8% reduction from his 1,849,437 pre-transaction holdings. The sale occurred near the stock's 52-week high of $25.88, and the stock has appreciated +36.3% over the prior 30 days and +42.2% over 90 days, suggesting the company's recent momentum has been strong. At the same-ticker level, Khaykin has executed five prior sales at VIAVI since 2025-12-02, with the most recent sale just one day before this transaction (2026-02-04), indicating a consistent pattern of recent liquidation activity. His cross-ticker track record shows 8 prior sales with an average 30-day return of +2.2%, though the measurable outcomes from his VIAV-specific trades show mixed results (ranging from +0.1% to +6.1% 30-day returns). The company carries a P/E of 158.25 on negative net income of -$48,100,000.00 against quarterly revenue of $369,300,000.00, indicating valuation metrics inconsistent with profitability despite the stock's strong recent price momentum.

VIAV CEO Khaykin sells 40,238 shares (50% of holdings) for $704,165 at $17.50; 5 consecutive sales in 3 days

KHAYKIN OLEG (President & CEO) executed a 40,238-share sale on 2025-12-05 at $17.50, reducing his holdings by exactly 50.0% to 40,238 shares remaining. This transaction is part of an unusual pattern: the insider sold 5 times in 3 consecutive days (2025-12-01 through 2025-12-05), signaling sustained liquidation activity. The timing is notable given the stock's recent momentum—VIAVI traded at $17.50 on the sale date while currently at $18.32, and has posted +5.0% over 30 days and +57.1% over 90 days, placing the stock at its 52-week high. The company's fundamentals present a mixed picture with revenue of $299,100,000.00 in the latest quarter offset by a net loss of $-21,400,000.00 and a highly elevated P/E of 261.71, suggesting the stock is pricing in significant growth expectations. The consecutive-day sell pattern and sustained reduction of CEO holdings warrant investor attention to whether this reflects confidence limits at current valuations or execution of a planned portfolio rebalancing schedule.

VIAV CEO Khaykin sells 73.4K shares in 2 transactions (Dec 3–4) for $1.3M at $17.10–$17.60, reducing holdings 47.7%.

Oleg Khaykin, President & CEO of VIAVI Solutions, executed two separate sales on December 3–4, 2025, totaling 73,442 shares for $1,275,077.20, reducing his holdings from 153,918 to 80,476 shares (a 47.7% reduction). The sales occurred at prices of $17.10 and $17.60, just below the current market price of $17.50 and near the 52-week high of $18.16. This sale follows four prior sell transactions at VIAV executed on December 1–2, suggesting a coordinated liquidation sequence. The company's current financial metrics show net income of $-21,400,000.00 against revenue of $299,100,000.00, with an elevated P/E ratio of 250.00 and recent strong 90-day price performance of +50.1%, creating context for the timing of this substantial equity reduction by the CEO.